Stock STAR STRIDES PHARMA SCIENCE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Strides Pharma Science Limited

Equities

STAR

INE939A01011

Market Closed - NSE India S.E.
Other stock markets
 07:40:47 2024-04-16 am EDT 		5-day change 1st Jan Change
839.5 INR +1.02% Intraday chart for Strides Pharma Science Limited +0.15% +29.30%
Apr. 09 Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs MT
Jan. 30 Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs
MT
Transcript : Strides Pharma Science Limited, Q3 2024 Earnings Call, Jan 30, 2024
Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Strides Pharma Science Arm Gets US FDA Nod for Pregabalin Capsules
MT
Strides Pharma Science's Swiss Unit to Sell Entire Stake in Eris Pharma
MT
Strides Pharma Science Arm Acquires Additional 25% Stake in Neviton Softech
MT
Strides Pharma Science Acquires Minority Stake in Two Renewable Energy Companies
MT
Strides Pharma Science Subsidiary Secures Credit Facility Worth INR319 Million
MT
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules
AQ
India's Nifty set to open at new record highs for second session in a row
RE
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules
CI
Strides Pharma Unit Gets US FDA Approval for Generic Bowel Prep Kit Solution
MT
Strides Pharma Global Pte. Limited Receives USFDA Approval for Generic Suprep®? Bowel Prep Kit
CI
Strides Pharma Science Arm Gets US FDA's Nod for Generic Seizure Treatment
MT
First African-Manufactured Combination Therapy For Seasonal Malaria Chemoprevention Receives WHO Prequalification [press release]
AQ
Strides Pharma Science Appoints COO
MT
Transcript : Strides Pharma Science Limited, Q2 2024 Earnings Call, Oct 30, 2023
Strides Pharma Science Limited Announces Change in Management
CI
Strides Pharma Science Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Strides Pharma Science to Sell Singapore Manufacturing Site for $15 Million
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. STAR Stock
  4. News Strides Pharma Science Limited